NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:05 AM
14/09/2026 15:05
NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 10:05 AM
Recent news on Cellectis SA
See all newsNASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:05 AM
Brief: Cellectis Receives FDA Rmat Designation For Lasme-Cel, The First Allogeneic Car-T Therapy In A Pivotal Trial For Patients With R/R B-All
Brief: Cema-Cel Pivotal Trial Interim Data Highlight Strength Of Cellectis’ Allogeneic Car-T Platform
France's Cellectis swings to net loss in Q4
Brief: Cellectis Q4 Operating Income USD -17.352 Million